Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  pan FGFR kinase inhibitor BGJ398
Find trials that include:  Any drugs shown
Results 1-6 of 6 for your search:
Start Over
BGJ398 and Imatinib Mesylate in Treating Patients with Untreated Advanced Gastrointestinal Stromal Tumor
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 14-140, NCI-2014-02117, NCT02257541
Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients with Untreated Metastatic Pancreatic Cancer
Status: Not yet active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 265214, NCI-2015-01597, NCT02575508
BGJ398 for Patients With Tumors With FGFR Genetic Alterations
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CBGJ398XUS04, NCI-2014-01999, NCT02160041
Pan FGFR Kinase Inhibitor BGJ398 in Treating Patients with FGFR1-3 Translocated, Mutated, or Amplified Recurrent Head and Neck Cancer
Status: Not yet active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: IRB14-1447, NCI-2016-01121, NCT02706691
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: CBGJ398X2101, NCI-2011-01165, 2009-010876-73, NCT01004224
BGJ398 in Treating Patients with Non-Muscle-Invasive Urothelial Cancer of the Bladder
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15-090, NCI-2016-00119, NCT02657486
Start Over